© 2021 MJH Life Sciences and OncLive. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
April 05, 2015
Experts discuss the clinical features, gene function, and medical management recommendations for six hereditary cancer syndromes.
April 01, 2015
James P. Stevenson, MD, discusses optimization of drug and patient selection for maintenance therapies in NSCLC, and how it will continue to be a research focus in today's environment of value-based care.
March 31, 2015
Jason J. Luke, MD, FACP, discusses the stark change in funding priorities by the United States for biomedical research, and the consequences of that.
March 29, 2015
BJ Rimel, MD, discuss the current literature surrounding antiangiogenesis agents in ovarian cancer.
March 27, 2015
The role of mTOR inhibition in breast cancer is evolving, and ongoing studies are evaluating biomarkers that will identify the patients who will benefit.